These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 16996204

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. BRCA1 germline mutations in Indian familial breast cancer.
    Valarmathi MT, A A, Deo SS, Shukla NK, Das SN.
    Hum Mutat; 2003 Jan; 21(1):98-9. PubMed ID: 12497638
    [Abstract] [Full Text] [Related]

  • 3. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SS, Das BC.
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [Abstract] [Full Text] [Related]

  • 4. Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population.
    Hussain I, ul Rehman S, Afroze D, Zahoor L, Abdullah S, Hafiz A, Shah ZA, Iqbal S, Shaffi M, Das BC, Siddiqi MA.
    Mutat Res; 2009 May 31; 676(1-2):5-10. PubMed ID: 19486858
    [Abstract] [Full Text] [Related]

  • 5. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM, Jassem E, Rosell R, Martínez-Roca M, Jassem J, Martínez-López E, Monzó M, Sánchez-Hernández JJ, Moreno I, Sánchez-Céspedes M.
    Oncogene; 1997 Dec 11; 15(24):2951-8. PubMed ID: 9416838
    [Abstract] [Full Text] [Related]

  • 6. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
    Haitian Z, Yunfei L, Jian Z, Jian L, Qinghua L, Fuqiang W.
    Breast; 2008 Dec 11; 17(6):563-7. PubMed ID: 18835712
    [Abstract] [Full Text] [Related]

  • 7. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M, Silva A, Rubio L, Alvarez C, Torrealba C, Salinas M, Tapia T, Faundez P, Palma L, Riccio ME, Paredes H, Rodriguez M, Cruz A, Rousseau C, King MC, Camus M, Alvarez M, Carvallo P.
    Breast Cancer Res Treat; 2006 Jan 11; 95(1):81-7. PubMed ID: 16261400
    [Abstract] [Full Text] [Related]

  • 8. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India.
    Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N, Das BC.
    Cancer Lett; 2005 Jan 31; 218(1):69-79. PubMed ID: 15639342
    [Abstract] [Full Text] [Related]

  • 9. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
    Kataki A, Gomatos I, Pararas N, Armakolas A, Panousopoulos D, Karantzikos G, Voros D, Zografos G, Markopoulos C, Leandros E, Konstadoulakis M.
    Clin Genet; 2005 Apr 31; 67(4):322-9. PubMed ID: 15733268
    [Abstract] [Full Text] [Related]

  • 10. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V.
    Neoplasma; 2006 Apr 31; 53(2):97-102. PubMed ID: 16575464
    [Abstract] [Full Text] [Related]

  • 11. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J.
    Cancer Res; 2009 Apr 15; 69(8):3625-33. PubMed ID: 19336573
    [Abstract] [Full Text] [Related]

  • 12. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
    Seo JH, Cho DY, Ahn SH, Yoon KS, Kang CS, Cho HM, Lee HS, Choe JJ, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS, Son GS, Lee JB, Koo BH.
    Hum Mutat; 2004 Oct 15; 24(4):350. PubMed ID: 15365993
    [Abstract] [Full Text] [Related]

  • 13. Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan.
    Amikura T, Sekine M, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, Obata K, Suzuki M, Yoshinaga M, Umesaki N, Satoh S, Enomoto T, Motoyama S, Nishino K, Haino K, Tanaka K, Japanese Familial Ovarian Cancer Study Group.
    Gynecol Oncol; 2006 Feb 15; 100(2):365-71. PubMed ID: 16337994
    [Abstract] [Full Text] [Related]

  • 14. [Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].
    Meng J, Shi YR, Niu RF, Fu L.
    Zhonghua Yi Xue Za Zhi; 2009 Jan 13; 89(2):79-82. PubMed ID: 19489266
    [Abstract] [Full Text] [Related]

  • 15. High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors.
    Manié E, Vincent-Salomon A, Lehmann-Che J, Pierron G, Turpin E, Warcoin M, Gruel N, Lebigot I, Sastre-Garau X, Lidereau R, Remenieras A, Feunteun J, Delattre O, de Thé H, Stoppa-Lyonnet D, Stern MH.
    Cancer Res; 2009 Jan 15; 69(2):663-71. PubMed ID: 19147582
    [Abstract] [Full Text] [Related]

  • 16. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
    Lalloo F, Varley J, Moran A, Ellis D, O'dair L, Pharoah P, Antoniou A, Hartley R, Shenton A, Seal S, Bulman B, Howell A, Evans DG.
    Eur J Cancer; 2006 May 15; 42(8):1143-50. PubMed ID: 16644204
    [Abstract] [Full Text] [Related]

  • 17. Germline BRCA1 mutation and survival analysis in familial breast cancer patients in Kerala; South India.
    Vinodkumar B, Syamala V, Abraham EK, Balakrishnan R, Ankathil R.
    J Exp Clin Cancer Res; 2007 Sep 15; 26(3):329-36. PubMed ID: 17987791
    [Abstract] [Full Text] [Related]

  • 18. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
    Salmon A, Amikam D, Sodha N, Davidson S, Basel-Vanagaite L, Eeles RA, Abeliovich D, Peretz T.
    Clin Oncol (R Coll Radiol); 2007 Sep 15; 19(7):490-3. PubMed ID: 17572079
    [Abstract] [Full Text] [Related]

  • 19. [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
    Mestiri S, Monastiri K, Ben Ahmed S, Bouaouina N, Presneau N, Bignon YJ, Khairi H, Chouchane L.
    Arch Inst Pasteur Tunis; 2000 Sep 15; 77(1-4):11-5. PubMed ID: 14658222
    [Abstract] [Full Text] [Related]

  • 20. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
    Konecny M, Vizvaryova M, Weismanova E, Ilencikova D, Mlkva I, Weismann P, Machackova G, Kausitz J.
    Neoplasma; 2007 Sep 15; 54(2):137-42. PubMed ID: 17319787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.